Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals A Grifoni, D Weiskopf, SI Ramirez, J Mateus, JM Dan, CR Moderbacher, ... Cell 181 (7), 1489-1501. e15, 2020 | 4002 | 2020 |
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection JM Dan, J Mateus, Y Kato, KM Hastie, ED Yu, CE Faliti, A Grifoni, ... Science 371 (6529), eabf4063, 2021 | 2925 | 2021 |
Induction of autophagy by spermidine promotes longevity T Eisenberg, H Knauer, A Schauer, S Büttner, C Ruckenstuhl, ... Nature cell biology 11 (11), 1305-1314, 2009 | 2051 | 2009 |
Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity CR Moderbacher, SI Ramirez, JM Dan, A Grifoni, KM Hastie, D Weiskopf, ... Cell 183 (4), 996-1012. e19, 2020 | 1778 | 2020 |
Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans J Mateus, A Grifoni, A Tarke, J Sidney, SI Ramirez, JM Dan, ZC Burger, ... Science 370 (6512), 89-94, 2020 | 1173 | 2020 |
The aging of the immune system D Weiskopf, B Weinberger, B Grubeck‐Loebenstein Transplant international 22 (11), 1041-1050, 2009 | 994 | 2009 |
Phenotype and kinetics of SARS-CoV-2–specific T cells in COVID-19 patients with acute respiratory distress syndrome D Weiskopf, KS Schmitz, MP Raadsen, A Grifoni, NMA Okba, H Endeman, ... Science immunology 5 (48), eabd2071, 2020 | 958 | 2020 |
The receptor-binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients L Premkumar, B Segovia-Chumbez, R Jadi, DR Martinez, R Raut, ... Science immunology 5 (48), eabc8413, 2020 | 890 | 2020 |
Properties of MHC class I presented peptides that enhance immunogenicity JJA Calis, M Maybeno, JA Greenbaum, D Weiskopf, AD De Silva, A Sette, ... PLoS computational biology 9 (10), e1003266, 2013 | 811 | 2013 |
T cells from patients with Parkinson’s disease recognize α-synuclein peptides D Sulzer, RN Alcalay, F Garretti, L Cote, E Kanter, J Agin-Liebes, C Liong, ... Nature 546 (7660), 656-661, 2017 | 754 | 2017 |
mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern RR Goel, MM Painter, SA Apostolidis, D Mathew, W Meng, AM Rosenfeld, ... Science 374 (6572), abm0829, 2021 | 742 | 2021 |
SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron A Tarke, CH Coelho, Z Zhang, JM Dan, ED Yu, N Methot, NI Bloom, ... Cell 185 (5), 847-859. e11, 2022 | 691 | 2022 |
Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells D Weiskopf, MA Angelo, EL de Azeredo, J Sidney, JA Greenbaum, ... Proceedings of the National Academy of Sciences 110 (22), E2046-E2053, 2013 | 620 | 2013 |
Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals A Tarke, J Sidney, N Methot, ED Yu, Y Zhang, JM Dan, B Goodwin, ... Cell Reports Medicine 2 (7), 2021 | 545 | 2021 |
T cell responses to SARS-CoV-2 spike cross-recognize Omicron R Keeton, MB Tincho, A Ngomti, R Baguma, N Benede, A Suzuki, K Khan, ... Nature 603 (7901), 488-492, 2022 | 512 | 2022 |
A single-dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-CoV-2 AO Hassan, NM Kafai, IP Dmitriev, JM Fox, BK Smith, IB Harvey, RE Chen, ... Cell 183 (1), 169-184. e13, 2020 | 511 | 2020 |
Biology of immune responses to vaccines in elderly persons B Weinberger, D Herndler-Brandstetter, A Schwanninger, D Weiskopf, ... Clinical Infectious Diseases 46 (7), 1078-1084, 2008 | 510 | 2008 |
Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases A Tarke, J Sidney, CK Kidd, JM Dan, SI Ramirez, ED Yu, J Mateus, ... Cell Reports Medicine 2 (2), 2021 | 502 | 2021 |
Imbalance of regulatory and cytotoxic SARS-CoV-2-reactive CD4+ T cells in COVID-19 BJ Meckiff, C Ramírez-Suástegui, V Fajardo, SJ Chee, A Kusnadi, ... Cell 183 (5), 1340-1353. e16, 2020 | 489 | 2020 |
Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy SA Apostolidis, M Kakara, MM Painter, RR Goel, D Mathew, K Lenzi, ... Nature medicine 27 (11), 1990-2001, 2021 | 444 | 2021 |